EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
66 hedge funds and large institutions have $14.6M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 8 increasing their positions, 28 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-5
Holders Change %
-7.04%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
8
Reduced
28
Closed
22
Calls
$14K
Puts
–
Net Calls
+$14K
Net Calls Change
-$77K
Top Buyers
1 |
Ameriprise
Minneapolis,
Minnesota
|
$6.05M |
2 |
RC
RBF Capital
San Francisco,
California
|
$275K |
3 |
Millennium Management
New York
|
$218K |
4 |
YIH
Y-Intercept (HK)
Hong Kong
|
$114K |
5 |
Verition Fund Management
Greenwich,
Connecticut
|
$106K |